Travel Vaccines: A US and European Perspective
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
As the cost of travel has decreased, more and more people are choosing to travel abroad for business and leisure. As a result, they can be exposed to pathogens non-endemic to their countries of origin. Ensuring that patients are vaccinated to reduce the risk of infection while travelling is an important tenet of practicing travel medicine. This report covers the management of travel vaccinations in the US and Europe, focusing on travel habits of residents to high-risk areas, current and future travel vaccines, and research and development strategies.
Scope
GlobalData’s Travel Vaccines: A US and European Perspective combines key opinion leader insight with in-house analyst expertise and research to provide an insight-rich look at vaccination in US and European travelers.
Components of the report include:
• Overview of Travel-Associated Diseases – Which diseases are vaccinated against in travelers.
• Habits of US and European Travelers – Which travel destinations carry the greatest risk of diseases.
• Travel Vaccine Management – How is the prescription and reimbursement of travel vaccines handled across the US and Europe.
• Established Disease Markets for Travel Vaccines – What are the current and pipeline products available for diseases currently vaccinated against in travelers.
• Emerging Disease Markets for Travel Vaccines – What diseases may be vaccinated against in travelers in the future, and which products are in the pipeline.
• Research and Development Strategies – How are travel vaccine-relevant clinical trials being designed, and what is required for regulatory approval in the US and EU.
Reasons to Buy
Develop business strategies by understanding the trends shaping and driving the travel vaccine market in the US and Europe.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the portfolios of various competitors.
Identify areas of unmet need within the travel vaccines market to help drive research and development towards future market opportunities.
Gain insights to help plan and design your clinical trials.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Identify key pricing and reimbursement strategies.
Boryung Pharmaceutical
Cadila Healthcare
China National Pharmaceutical Group
CPL Biologicals
Dynavax Technologies
Finlay Institute
GlaxoSmithKline
International Vaccine Institute
Livzon Pharmaceutical Group
Merck & Co
PaxVax
Pfizer
Sanofi Pasteur
Shandong Hengye Biotech
Takeda
The National Institute of Allergy and Infectious Diseases
Vabiotech
Valneva
VBI Vaccines
Wellcome Trust
Table of Contents
Frequently asked questions
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.